Literature DB >> 6475457

Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma.

G Stenström, L Sjöström, U Smith.   

Abstract

Sixty patients undergoing operation for phaeochromocytoma were investigated in the pre- and postoperative states with respect to fasting blood glucose levels. When 6 previously known or suspected diabetics were excluded, preoperative diabetes (fasting blood glucose levels greater than or equal to 7.0 mmol/l) were found in 3 of 13 (23%) with sustained hypertension, in 6 of 12 (50%) with sustained hypertension associated with paroxysms and in 4 of 24 (17%) with paroxysmal hypertension. None of the 5 patients with atypical clinical symptoms had glucose levels greater than or equal to 7.0 mmol/l. In the groups of patients with particularly high urinary excretion of catecholamines and vanilmandelic acid higher blood glucose levels were also found. The postoperative blood glucose levels in the follow-up study were normal and less than 5.8 mmol/l in all cases except in 3 of the 4 still living patients with a previously known diabetes and in 1 patient with a malignant tumour. Thus, manifest diabetes, defined as fasting glucose levels greater than or equal to 7.0 mmol/l, is frequently present in patients with phaeochromocytoma (24% in the present study) and the diabetes is reversed by removal of the tumour.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475457     DOI: 10.1530/acta.0.1060511

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  13 in total

1.  Endocrine pancreatic function in pheochromocytoma.

Authors:  N Sicolo; G Federspil; C B De Palo; R Vettor; C Martini; C Scandellari
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

2.  Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors.

Authors:  I Lager; S Attvall; B M Eriksson; H von Schenk; U Smith
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

3.  Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome.

Authors:  A Gursoy; M F Erdogan; N Kamel
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

4.  What is type 2 diabetes?

Authors:  Galina Smushkin; Adrian Vella
Journal:  Medicine (Abingdon)       Date:  2010-11-01

Review 5.  Skeletal muscle insulin resistance in endocrine disease.

Authors:  Melpomeni Peppa; Chrysi Koliaki; Panagiotis Nikolopoulos; Sotirios A Raptis
Journal:  J Biomed Biotechnol       Date:  2010-03-15

6.  Composite Pheochromocytoma-Ganglioneuroma of the Adrenal Gland: An Uncommon Entity with Distinctive Clinicopathologic Features.

Authors:  King-Yin Lam; Chung-Yau Lo
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

7.  Pheochromocytoma in Urologic Practice.

Authors:  Nikhil Waingankar; Gennady Bratslavsky; Camilo Jimenez; Paul Russo; Alexander Kutikov
Journal:  Eur Urol Focus       Date:  2016-09-28

8.  An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction.

Authors:  Jake Natalini; Hala Borno; Lan Jin; Trevor Jensen
Journal:  JRSM Open       Date:  2017-06-05

9.  Association between higher urinary normetanephrine and insulin resistance in a Japanese population.

Authors:  Masaya Murabayashi; Makoto Daimon; Hiroshi Murakami; Tomoyuki Fujita; Eri Sato; Jutaro Tanabe; Yuki Matsuhashi; Shinobu Takayasu; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Kaori Sawada; Kazushige Ihara
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

10.  Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases.

Authors:  Minmin Han; Xiaoming Cao; Changjian Zhao; Luyang Yang; Nan Yin; Pengliang Shen; Jin Zhang; Fei Gao; Yi Ren; Dong Liang; Jing Yang; Yi Zhang; Yunfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.